The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula:. The present invention is also related a method of treating a subject with a disease which can be ameliorated by inhibition of poly(ADP-ribose)polymerase (PARP). The definitions of the variables are provided herein.本發明係關於一種醫藥組合物，該醫藥組合物包含醫藥學上可接受之載劑或稀釋劑及由以下結構式表示之化合物：。 本發明亦係關於一種治療患有可藉由抑制聚(ADP-核糖)聚合酶(poly(ADP-ribose)polymerase；PARP)經改善之疾病之個體的方法。本文中提供變數之定義。
